C.Ped study materials
C.Ped study resources

C.Ped cheat sheet

C.Ped · Keep the key ideas within reach.

Quick reference

Patient Assessment

  • Palpate dorsalis pedis and posterior tibial pulses bilaterally; absent pulses, dependent rubor, or hair loss warrant vascular evaluation before any device is fabricated.

  • Ankle-brachial index below 0.90 indicates peripheral arterial disease; an index above 1.30 indicates non-compressible calcified vessels, common in long-standing diabetes.

  • 10-g Semmes-Weinstein monofilament: inability to perceive the force at one or more plantar test sites equals loss of protective sensation; pair with 128-Hz tuning fork vibration testing.

  • Subtalar joint neutral is the position of talonavicular congruency with no medial or lateral bulging; all forefoot-to-rearfoot measurements are taken from this reference.

  • Resting calcaneal stance position of 2 to 6 degrees everted is typical; forefoot varus means the forefoot is inverted relative to a line perpendicular to the rearfoot in subtalar neutral.

  • Ankle dorsiflexion with the knee extended of less than 10 degrees suggests gastrocnemius or soleus tightness; the Silfverskiold test separates gastrocnemius from soleus limitation.

  • Three gait rockers drive the ground reaction force: heel rocker at initial contact, ankle rocker in midstance, forefoot rocker at push-off; pain localizes the rocker to be offloaded.

  • Wagner ulcer classification runs 0 to 5: 0 intact skin with deformity, 1 superficial ulcer, 2 deep to tendon or bone, 3 abscess or osteomyelitis, 4 partial gangrene, 5 whole-foot gangrene.

  • Leg length is screened by tape measure from anterior superior iliac spine to medial malleolus; a difference under 2 cm is usually managed with an internal heel lift.

Quick reference

Formulation of the Treatment Plan

  • Treatment goals are ranked in this order: redistribute pressure, accommodate fixed deformity, add cushioning, correct flexible deformity only, and control unwanted motion.

  • Medial compartment knee osteoarthritis is offloaded with a lateral wedge insole that reduces the external knee adduction moment; avoid this when lateral compartment disease predominates.

  • Neuropathic plantar ulcer: total contact casting is the gold standard, contraindicated with active infection, osteomyelitis, or severe ischemia, in which case a CROW or removable walker is used.

  • Foot drop prescription: a hinged AFO blocks plantarflexion while permitting stance-phase dorsiflexion; a solid AFO is chosen when mediolateral ankle stability is also required.

  • Diabetes: prescribe extra-depth footwear with removable insoles providing at least 3/8 inch of extra depth, paired with a multi-density insert and no seams over bony prominences.

  • Metatarsalgia or first-ray amputation: a stiff forefoot with a rocker-bottom sole reduces peak pressure at the metatarsal heads during terminal stance.

  • Heel lifts greater than 2 cm are placed on the shoe or split between shoe and orthosis, because an internal lift of that height causes heel slippage and shoe fit failure.

  • Flexible pes planus is managed with a medial arch shell plus an intrinsic rearfoot post of roughly 4 to 6 degrees; a rigid flatfoot is accommodated, not corrected.

Quick reference

Implementation of the Treatment Plan

  • Positive model modification: add plaster for arch fill, grind reliefs over bony prominences, and smooth the model before vacuum forming so pressure areas are built into the shell.

  • Polypropylene 3 to 5 mm thick is vacuum formed at approximately 350 to 400 degrees Fahrenheit and must cool fully under vacuum to prevent warping.

  • Typical multi-density layup: rigid base shell (polypropylene or carbon), mid-layer cushion (PPT or Poron), top cover (Plastazote or leather).

  • Trimlines run medially to the first metatarsal head, laterally to cover the fifth metatarsal base, with heel cup height just below the malleoli unless more control is needed.

  • Break-in schedule: 1 to 2 hours on day one, increasing 1 to 2 hours daily; redness persisting more than 20 to 30 minutes after removal indicates a modification is needed.

  • Shoe fit is measured weight bearing at the end of the day: 3/8 to 1/2 inch of toe space, shoe widest point matching the first and fifth metatarsal heads, snug heel counter.

  • Dispensing check: no blanching, no focal pressure on metatarsal heads, toes clear the toe box, and the patient can don and doff the device independently.

  • Shell edges contacting the navicular, malleoli, or fifth metatarsal base are flared or ground to remove focal pressure before delivery.

Quick reference

Follow-Up and Maintenance

  • Standard recheck occurs about two weeks after dispensing, then annually, and at any report of skin change, pain, or altered gait.

  • Diabetes: inspect both feet at every visit and at each footwear replacement; therapeutic shoes and inserts are renewed annually under most coverage policies.

  • Charcot surveillance: an interfoot skin temperature difference greater than 2 degrees Celsius suggests active inflammation and calls for immobilization and referral.

  • Pediatric reassessment occurs every 3 to 6 months because growth alters fit; shoe size is re-measured at each visit along with the orthosis.

  • Expected service life: foam and EVA devices 1 to 2 years, rigid thermoplastic devices 3 to 5 years, leather uppers roughly 12 to 18 months under heavy use.

  • Ulcer follow-up tracks area and depth serially; healing that stalls over 2 to 4 weeks prompts reassessment of offloading and vascular status.

  • Follow-up documentation includes pain score, activity level, skin integrity, wear time, and every adjustment made to the device.

Quick reference

Practice Management and Professional Responsibility

  • The Medicare therapeutic shoe benefit covers one pair of shoes and up to three pairs of inserts per calendar year for eligible beneficiaries with a physician certification and order.

  • The KX modifier on a claim attests that the clinical documentation on file supports medical necessity for the billed device.

  • An Advance Beneficiary Notice must be issued before furnishing an item likely to be denied as not medically necessary so the patient accepts financial responsibility.

  • PDAC reviews manufacturer documentation and assigns the correct L-code; claims submitted with an unverified code are subject to denial and recoupment.

  • Required documentation elements: presenting history, physical findings, diagnosis, functional limitation, device description with rationale, and patient response.

  • Record retention follows state and payer rules; a common standard is at least 7 years, and longer for records of minors.

  • C.Ped scope covers footwear and foot orthoses below the knee; fabricating or fitting higher-level orthoses or prostheses requires separate O&P credentialing.

  • The HIPAA minimum necessary rule limits access, use, and disclosure of protected health information to what the specific purpose requires.